Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
The currently available diphtheria-tetanus-whole-cell pertussis (DTP) vaccines are associated with a variety of problems, including undesirable side effects and inconsistent efficacy. These problems are probably related to the poor definition of such vaccines, especially with respect to the whole-ce...
Na minha lista:
| Udgivet i: | Infect Immun |
|---|---|
| Principais autores: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1994
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186128/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7507893/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.62.2.449-456.1994 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|